Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
Cancer Therapies02:49

Cancer Therapies

9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

542
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
542
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

844
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
844
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Persistent disparities in head and neck cancer survival in the United States.

Cancer causes & control : CCC·2026
Same author

Clinical outcomes of ferroptosis-inducing agents in glioblastoma: A systematic review of clinical trials.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same author

Palliative Care Coaching for Family Caregivers of Patients With Advanced Cancer: A Randomized Clinical Trial.

JAMA network open·2026
Same author

A WEb-Accessible comprehensiVE platform for automatic vestibular schwannoma segmentation and longitudinal volumetric tracking.

Neuro-oncology advances·2026
Same author

Making cancer support services sustainable in value-based care.

The American journal of managed care·2026
Same author

Laser interstitial thermal therapy (LITT) for brain metastases: a systematic review and pooled analysis of Efficacy/Safety and the role of combination treatments.

Journal of neuro-oncology·2026
Same journal

Nationwide Trends in Colorectal Cancer Screening by the End of the COVID-19 Pandemic: Racial/Ethnic Differences and Opportunities.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Evaluation of the Impact of Adjuvant Immunotherapy in Merkel Cell Carcinoma.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Payers' Views on Insurance Coverage for Confirmatory Diagnostics After a Noncovered Multicancer Early Detection (MCED) Test.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

The Evolving Clinical Utility of Gene Expression Profiling in Cutaneous Melanoma.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
See all related articles

Related Experiment Video

Updated: Jan 11, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.9K

Team-Based Versus Technology-Based Supportive Cancer Care: A Mixed Methods Study of Multi-Site Implementation.

Sacha Moufarrej1, Emily H Wood2, Niharika Dixit3

  • 11University of California San Diego School of Medicine, San Diego, CA.

Journal of the National Comprehensive Cancer Network : JNCCN
|November 10, 2025
PubMed
Summary
This summary is machine-generated.

Supportive cancer care (SCC) is vital but faces implementation barriers. Team-based SCC shows promise, but technology-based approaches may worsen disparities without addressing infrastructure and policy challenges.

Related Experiment Videos

Last Updated: Jan 11, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.9K

Area of Science:

  • Oncology
  • Health Services Research
  • Implementation Science

Background:

  • Supportive cancer care (SCC), encompassing advance care planning and symptom management, is a national recommendation for cancer patients.
  • Persistent barriers hinder the effective delivery of SCC, necessitating innovative implementation strategies.
  • A multisite clinical trial was initiated to compare team-based SCC led by lay health educators with technology-based SCC education delivery.

Purpose of the Study:

  • To identify implementation barriers and facilitators for different SCC delivery models.
  • To evaluate the comparative effectiveness, implementation, adoption, and sustainability of team-based versus technology-based SCC approaches.
  • To understand the impact of SCC on total costs of care for potential payer reimbursement.

Main Methods:

  • A convergent parallel mixed methods approach was used, combining semistructured interviews and surveys with study staff at 26 cancer clinics.
  • Qualitative data from interviews were analyzed using content analysis, while survey data were analyzed using descriptive statistics.
  • The Consolidated Framework for Implementation Research (CFIR) and RE-AIM framework guided study design and analysis.

Main Results:

  • Participants universally recognized the essential nature of SCC for cancer patients.
  • Infrastructural and cultural barriers, including funding, prioritization, stigma, and diverse patient needs, were identified.
  • While team-based SCC received broad support, concerns were raised that technology-based approaches alone could exacerbate cancer disparities.

Conclusions:

  • Significant infrastructural, organizational, and policy factors critically influence the adaptability and sustainability of SCC in clinical practice.
  • These factors are likely to impact the comparative effectiveness of the evaluated SCC approaches in the ongoing trial.
  • Addressing identified barriers is crucial for successful implementation and long-term sustainability of supportive cancer care services.